We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Treasury Department Regulations Could Halt Pfizer-Allergan Merger
Treasury Department Regulations Could Halt Pfizer-Allergan Merger
The largest drug merger of all time could be at risk of falling through after the U.S. Treasury Department late Monday issued a set of regulations that reduce the benefit of tax inversion deals.